Neutrophil CD64 expression as a longitudinal biomarker for severe disease and acute infection in critically ill patients. (27th August 2016)

• Record Type: Journal Article
• Authors: de Jong, E.; de Lange, D. W.; Beishuizen, A.; van de Ven, P. M.; Girbes, A. R. J.; Huisman, A.
• Is Part Of: International journal of laboratory hematology. Volume 38:Number 5(2016:Oct.)
• Page Start: 576
• Page End: 584
• Publication Date: 2016-08-27
• Subjects: CD64 -- biomarker -- infection -- sepsis -- critically ill; Hematology -- Periodicals; Blood -- Diseases -- Periodicals; Hematology -- Periodicals; 616.15005
• DOI: 10.1111/ijlh.12545
• Languages: English
• ISSNs: 1751-5521

Abstract

Summary: Introduction: Neutrophilic granulocytes express cluster of differentiation 64 (CD64) antigen upon activation. CD64 can be used as a marker of bacterial infection and sepsis. The goal of this study was to determine whether CD64 is a useful biomarker for critically ill patients and analyze longitudinal measurements with regard to outcome and sepsis severity. Methods: In this prospective observational study, CD64 analysis was performed daily until discharge from ICU or death. Demographics, clinical, laboratory data, and outcome defined as 28‐day survival were recorded. Patients were included when admitted to the ICU with sepsis, severe sepsis, or septic shock and within 24 h from start of antibiotic treatment. Results: Hundred and fifty‐five consecutive patients were enrolled. At baseline, a difference in CD64 of 2.26 (1.33–4.47) vs . 1.49 (0.89–2.24) ( P = 0.004) was seen between patients with a positive culture and negative culture. CD64 at day 1 was higher with patients with septic shock when compared with sepsis ( P = 0.012). No difference of CD64 between survivors and nonsurvivors was seen. Conclusion: This study demonstrated that CD64 discriminates between critically ill patients with culture positive and negative sepsis and correlates with severity of disease. However, CD64 index is not a good predictor for 28‐day mortality in the critically ill patient.